Flow cytometry and immunofluorescence analyses confirmed LEF1 co‐localisation with both CD8+ effector T cells and CD4+ memory T cells, with significantly enhanced LEF1 expression in AAA specimens versus controls. The gene discussed is LEF1; the disease is triple-A syndrome.